Torticollis
13
2
2
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
15.4%
2 terminated out of 13 trials
75.0%
-11.5% vs benchmark
8%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation
Using Technology for Prediction and Prevention of Infant Torticollis and Plagiocephaly
Effect of the Visual Information Change in Functional Dystonia
Evaluating the Impact of a New Complement to Physiotherapy Intervention for Positional Torticollis in Infants
A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA
Is Home Positioning Time Associated With Torticollis Rate of Recovery?
Comparative Trial of Botox in the Management of Children With Congenital Muscular Torticollis
Effects of Botulinum Toxin in Cervical Dystonia
MDs on Botox Utility (MOBILITY)
Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia
Botulinum Toxin Injection Efficiency
The Physiology of Tricks